Multiple evolutionary routes to cytoskeletal arborization revealed by the rhizarian amoeba Filoreta ramosa
Current Biology · 2026-11 · 36 (21) · 5508-5522.e4
DOI: 10.1016/j.cub.2026.09.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Biology, 2026-11. Verfasst von Sarah L Guest und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Massachusetts Amherst, Department of Biology, 611 N. Pleasant St., Amherst, MA 01003, USA. Hauptthemen laut MEDLINE: Cytoskeleton, Biological Evolution. Die Arbeit nennt 77 Literaturangaben. Gefördert von: National Institute of Allergy and Infectious Diseases, Marine Biological Laboratory, National Aeronautics and Space Administration.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Massachusetts Amherst, Department of Biology, 611 N. Pleasant St., Amherst, MA 01003, USA.
- University of California, Davis, Department of Microbiology and Molecular Genetics, One Shields Avenue, Davis, CA 95616, USA. Electronic address: scdawson@ucdavis.edu.
Förderung
- National Institute of Allergy and Infectious Diseases
- Marine Biological Laboratory
- National Aeronautics and Space Administration
Zitieren
APA
Guest, S. L., & Dawson, S. C. (2026). Multiple evolutionary routes to cytoskeletal arborization revealed by the rhizarian amoeba Filoreta ramosa. Current Biology, 36(21), 5508-5522.e4. https://doi.org/10.1016/j.cub.2026.09.032
Vancouver
Guest SL, Dawson SC. Multiple evolutionary routes to cytoskeletal arborization revealed by the rhizarian amoeba Filoreta ramosa. Current Biology. 2026;36(21):5508-5522.e4. doi:10.1016/j.cub.2026.09.032
BibTeX
@article{Guest2026,
author = {Guest, Sarah L and Dawson, Scott C},
title = {Multiple evolutionary routes to cytoskeletal arborization revealed by the rhizarian amoeba Filoreta ramosa},
journal = {Current Biology},
year = {2026},
volume = {36},
number = {21},
pages = {5508--5522.e4},
doi = {10.1016/j.cub.2026.09.032}
}
EUVIMED